Evidence map›Paper›PMID 25486561›Full record

ReviewCell cycle (Georgetown, Tex.)2014

The Fanconi anemia ID2 complex: dueling saxes at the crossroads.

Rebecca A Boisvert, Niall G Howlett

Open access · bronzeAbstract readReview
In one paragraph

Review in Cell cycle (Georgetown, Tex.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. The Plant cell · 2018
    Article
  13. Article
  14. Review
  15. Article
  16. Fork Protection and Therapy Resistance in Hereditary Breast Cancer.Cold Spring Harbor symposia on quantitative biology · 2017
    Article
  17. Review
  18. Article
  19. Article
  20. Fanconi anemia pathway regulates convergent transcription-induced cell death at trinucleotide repeats in human cells.Postdoc journal : a journal of postdoctoral research and postdoctoral affairs · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Rebecca A Boisverta Department of Cell and Molecular Biology ; University of Rhode Island ; Kingston , RI USA.
Niall G Howlett
University of Rhode Island · US

Funding

Regulation of the Mono-Ubiquitination of the Fanconi Anemia D2 ProteinR01HL101977 · NHLBI · UNIVERSITY OF RHODE ISLAND · PI HOWLETT, NIALL GEORGE · 2011 to 2015
$1.3M
NHLBI NIH HHS R01 HL101977
6 · The paper itself

Abstract

Fanconi anemia (FA) is a rare recessive genetic disease characterized by congenital abnormalities, bone marrow failure and heightened cancer susceptibility in early adulthood. FA is caused by biallelic germ-line mutation of any one of 16 genes. While several functions for the FA proteins have been ascribed, the prevailing hypothesis is that the FA proteins function cooperatively in the FA-BRCA pathway to repair damaged DNA. A pivotal step in the activation of the FA-BRCA pathway is the monoubiquitination of the FANCD2 and FANCI proteins. Despite their importance for DNA repair, the domain structure, regulation, and function of FANCD2 and FANCI remain poorly understood. In this review, we provide an overview of our current understanding of FANCD2 and FANCI, with an emphasis on their posttranslational modification and common and unique functions.

Indexed as

DNADNA RepairFanconi AnemiaFanconi Anemia Complementation Group D2 ProteinFanconi Anemia Complementation Group ProteinsHumansNucleosomesProtein Processing, Post-TranslationalProtein Structure, TertiaryDNAFANCI protein, humanFanconi Anemia Complementation Group D2 ProteinFanconi Anemia Complementation Group ProteinsNucleosomesAML , acute myeloid leukemiaAPC/C, anaphase-promoting complex/cyclosomeAPH, aphidicolinARM, armadillo repeat domainAT, ataxia-telangiectasiaATM, ataxia-telangiectasia mutatedATR, ATM and Rad3-relatedBAC, bacterial-artificial-chromosomeBS, Bloom syndromeChIP-seq, CHIP sequencingCtBP, C-terminal binding proteinCtIP, CtBP-interacting proteinCUE, coupling of ubiquitin conjugation to endoplasmic reticulum degradationDNA interstrand crosslink repairDNA repairEPS15, epidermal growth factor receptor pathway substrate 15FA, Fanconi anemiaFAN1, FANCD2-associated nuclease1FANCD2FANCIFanconi anemiaFISH, fluorescence in situ hybridizationHECT, homologous to E6-AP Carboxy TerminusHJ, Holliday junctionHR, homologous recombinationiPOND, isolation of proteins on nascent DNAMCM2-MCM7, minichromosome maintenance 2–7MEFs, mouse embryonic fibroblastsMMC, mitomycin CMRN, MRE11/RAD50/NBS1NLS, nuclear localization signalPCNA, proliferating cell nuclear antigenPIKK, phosphatidylinositol-3-OH-kinase-like family of protein kinasesPIP-box, PCNA-interacting protein motifPOL κ, DNA polymerase κRACE, rapid amplification of cDNA endsRING, really interesting new geneRTK, receptor tyrosine kinaseSCF, Skp1/Cullin/F-box protein complexSCKL1, seckel syndromeSILAC, stable isotope labeling with amino acids in cell cultureSLD1/SLD2, SUMO-like domainsSLIM, SUMO-like domain interacting motifTIP60, 60 kDa Tat-interactive proteinTLS, Translesion DNA synthesisUAF1, USP1-associated factor 1UBD, ubiquitin-binding domainubiquitinUBZ, ubiquitin-binding zinc fingerUFB, ultra-fine DNA bridgesUIM, ubiquitin-interacting motifULD, ubiquitin-like domainUSP1, ubiquitin-specific protease 1VRR-nuc, virus-type replication repair nuclease

Identifiers

PMID25486561
PMCPMC4612647
OpenAlexW1966730768

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.